Niko Bell writes at Xtra:
Ontario’s provincial drug program will now cover a drug that protects people from being infected with HIV.
According to the Ministry of Health’s most recent update to the list of drugs it subsidizes, coverage for PrEP starts on Sept 28, 2017.
The pre-exposure prophylaxis drug (PrEP) is a combination of the drugs tenofovir and emtricitabine, which taken daily are highly effective at preventing the spread of HIV.
Until recently, Canadians who wanted PrEP only had access to the brand-name drugs, produced by Gilead Sciences, which cost nearly $1,000 a month.